CLINICAL TRIAL SOLUTIONS

Full Service: Phase II/III CRO

Get Phase II-III clinical trial support from a CRO that works collaboratively from start to end.

How can we support you?

Explore our Phase II-III CRO Services

PharPoint works diligently to help clients plan, manage, and analyze effective Phase II-III clinical trials. Whether you are looking for individual service support or looking to fully outsource your trial operations, our team is happy to chat.

Site Feasibility

Our analysis and insight can help sponsors effortlessly identify effective sites that can meet study goals.

Clinical Operations

Our team works to ensure study excellence and transparent collaboration between CRO, site, and Sponsor.

Clinical Data Management

Work with a clinical data management team that prioritizes your data from day one.

Biostatistics & Statistical Programming

Our consultative approach to biostatistics services includes a level of responsiveness, support, and proactiveness that is unmatched within the industry.


THE PHARPOINT DIFFERENCE

Helping sponsors meet their Phase II and Phase III study goals

AN EXPERIENCED TEAM

For Phase II-III Success

PharPoint aligns sponsors with teammates that have the right knowledge and experience to proactively identify factors critical to study success and mitigate potential study challenges. Working with the PharPoint team also means clear communication pathways and access to senior resources.

WORK COLLABORATIVELY

with a team that works without silos

From the start, the PharPoint team works collaboratively across functions to ensure study decisions are made with input from multiple perspectives. This connected approach helps us better anticipate challenges, accelerate timelines, and support deliverables that have our clients end goals in mind.

GET RESULTS FASTER

with PharPoint’s Industry-Best Biometrics Timelines

At every step, PharPoint’s standard biometrics CRO timelines are industry-best. Throughout your study, clean data are soft locked, reducing the number of subjects needing to be locked following Last Participant, Last Visit (LPLV) and decreasing the timeline to database lock to only 5 days after final Source Document Verification (SDV).

Biometrics CRO Timelines: PharPoint vs. Industry

Explore Related Resources

What makes database design smart?

What makes database design “smart”?

What makes database design "smart," and when should a sponsor start thinking about data collection and analysis? PharPoint programmer Michelle M. explains.
Key Components for Ensuring Quality Statistical Output

Key Components for Ensuring Quality Statistical Output

How do our experts produce quality statistical analyses? Proper planning, processes & review are critical.
How to Perform non-eCRF Data Reconciliation

How to Perform non-eCRF Data Reconciliation

How do you perform non-eCRF data (ECG, Labs, PK) reconciliation in EDC platforms like Medrio? A PharPoint clinical trial expert answers as part of our #askaclinicaltrialexpert blog series.
Choosing an EDC Provider Ask a CRO Series

Choosing an EDC Provider: Ask a CRO Series

For our upcoming study, we know we want to use EDC—but there are so many options. How should we choose an EDC provider?
Adaptive Trial Design and the CRO Landscape

Adaptive Trial Design and the CRO Landscape

Learn more about the shifting CRO landscape, as PharPoint's manager of programming technologies discusses adaptive trial design and outsourcing with EDC provider Medrio.
How and When to Consider a Data Monitoring Committee

How and When to Consider a Data Monitoring Committee

How and when should you consider a DMC (also known as a DSMB, DSMC, or IDMC)? Learn more in this brief video.